— Know what they know.
Not Investment Advice
Also trades as: VIRP.PA (PAR) · $vol 2M

VRBCF OTC

Virbac S.A.
1W: +0.0% 1M: +0.0% 3M: -5.7% YTD: +10.8% 1Y: +10.8% 3Y: -3.4% 5Y: +14.1%
$383.25
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 37 · $3.2B mcap · 4M float · 0.0000% daily turnover · Short 73% of daily vol
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.2B
52W Range346-436.32
Volume1
Avg Volume2
Beta0.78
Dividend$1.66
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOPaul Martingell
Employees6,442
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2013-04-17
13e rue LID - BP 27
Carros, PA 06511
FR
33 4 92 08 71 00
About Virbac S.A.

Virbac S.A. is a leading global animal health company that develops, produces, and distributes a comprehensive array of products and services designed for both domestic pets and livestock. The company maintains a significant international presence, operating across numerous regions including France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Its extensive portfolio encompasses solutions for disease prevention (such as vaccines), oral hygiene, reproductive health, dermatological conditions, parasite control, and diagnostics. Additionally, Virbac supplies various veterinary pharmaceuticals, including antibiotics, specialized medications for anesthesia, geriatric care, and behavioral issues, as well as injectable micronutrients and aquaculture products. The company also offers animal nutrition products (pet food) and electronic identification systems. Virbac primarily serves the needs of veterinarians, farmers, and individual pet owners. Established in 1968, the company is headquartered in Carros, France.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms